Annual Operating Expenses
$25.15 M
-$646.00 K-2.50%
31 December 2023
Summary:
Enlivex Therapeutics annual total operating expenses is currently $25.15 million, with the most recent change of -$646.00 thousand (-2.50%) on 31 December 2023. During the last 3 years, it has risen by +$15.37 million (+157.04%). ENLV annual operating expenses is now -2.50% below its all-time high of $25.80 million, reached on 31 December 2022.ENLV Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$2.99 M
-$964.00 K-24.41%
30 June 2024
Summary:
Enlivex Therapeutics quarterly total operating expenses is currently $2.99 million, with the most recent change of -$964.00 thousand (-24.41%) on 30 June 2024. Over the past year, it has dropped by -$2.64 million (-46.94%). ENLV quarterly operating expenses is now -61.94% below its all-time high of $7.84 million, reached on 31 December 2022.ENLV Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENLV Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.5% | -46.9% |
| 3 y3 years | +157.0% | -22.7% |
| 5 y5 years | +374.6% | +40.8% |
ENLV Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -2.5% | +157.0% | -61.9% | at low |
| 5 y | 5 years | -2.5% | +374.6% | -61.9% | +57.5% |
| alltime | all time | -2.5% | >+9999.0% | -61.9% | +193.4% |
Enlivex Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $2.99 M(-24.4%) |
| Mar 2024 | - | $3.95 M(-35.2%) |
| Dec 2023 | $25.15 M(-2.5%) | $6.09 M(+8.2%) |
| Sept 2023 | - | $5.63 M(-15.4%) |
| June 2023 | - | $6.65 M(-2.0%) |
| Mar 2023 | - | $6.78 M(-13.5%) |
| Dec 2022 | $25.80 M(+33.7%) | $7.84 M(+38.2%) |
| Sept 2022 | - | $5.68 M(-3.3%) |
| June 2022 | - | $5.87 M(-8.3%) |
| Mar 2022 | - | $6.40 M(-18.0%) |
| Dec 2021 | $19.29 M(+97.1%) | $7.81 M(+102.2%) |
| Sept 2021 | - | $3.86 M(+1.5%) |
| June 2021 | - | $3.81 M(+0.2%) |
| Mar 2021 | - | $3.80 M(+2.8%) |
| Dec 2020 | $9.79 M(+13.5%) | $3.70 M(+88.7%) |
| Sept 2020 | - | $1.96 M(-12.3%) |
| June 2020 | - | $2.23 M(+17.8%) |
| Mar 2020 | - | $1.90 M(-33.2%) |
| Dec 2019 | $8.62 M(+62.7%) | $2.84 M(+33.9%) |
| Sept 2019 | - | $2.12 M(+63.5%) |
| June 2019 | - | $1.30 M(-45.1%) |
| Mar 2019 | - | $2.36 M(+14.2%) |
| Dec 2018 | $5.30 M(+144.1%) | $2.07 M(+66.6%) |
| Sept 2018 | - | $1.24 M(+46.3%) |
| June 2018 | - | $848.00 K(-25.7%) |
| Mar 2018 | - | $1.14 M(-135.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $2.17 M(-86.3%) | -$3.20 M(-396.7%) |
| Sept 2017 | - | $1.08 M(-34.7%) |
| June 2017 | - | $1.65 M(-37.5%) |
| Mar 2017 | - | $2.64 M(-14.1%) |
| Dec 2016 | $15.87 M(+2.5%) | $3.07 M(-32.9%) |
| Sept 2016 | - | $4.58 M(+23.0%) |
| June 2016 | - | $3.72 M(-17.1%) |
| Mar 2016 | - | $4.49 M(-7.1%) |
| Dec 2015 | $15.48 M(+118.6%) | $4.83 M(+34.7%) |
| Sept 2015 | - | $3.59 M(-4.0%) |
| June 2015 | - | $3.74 M(+12.7%) |
| Mar 2015 | - | $3.32 M(+3.8%) |
| Dec 2014 | $7.08 M(+516.7%) | $3.20 M(+50.1%) |
| Sept 2014 | - | $2.13 M(+91.5%) |
| June 2014 | - | $1.11 M(+73.5%) |
| Mar 2014 | - | $641.00 K(-18.2%) |
| Dec 2013 | $1.15 M(+408.0%) | $784.00 K(+308.3%) |
| Sept 2013 | - | $192.00 K(+43.3%) |
| June 2013 | - | $134.00 K |
| Dec 2012 | $226.00 K(-84.7%) | - |
| Dec 2002 | $1.47 M(-19.6%) | - |
| Dec 2001 | $1.83 M(+29.5%) | - |
| Dec 2000 | $1.42 M(+102.7%) | - |
| Dec 1999 | $698.40 K(-56.7%) | - |
| Dec 1998 | $1.61 M(-29.3%) | - |
| Dec 1997 | $2.28 M | - |
FAQ
- What is Enlivex Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Enlivex Therapeutics?
- What is Enlivex Therapeutics annual operating expenses year-on-year change?
- What is Enlivex Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Enlivex Therapeutics?
- What is Enlivex Therapeutics quarterly operating expenses year-on-year change?
What is Enlivex Therapeutics annual total operating expenses?
The current annual operating expenses of ENLV is $25.15 M
What is the all time high annual operating expenses for Enlivex Therapeutics?
Enlivex Therapeutics all-time high annual total operating expenses is $25.80 M
What is Enlivex Therapeutics annual operating expenses year-on-year change?
Over the past year, ENLV annual total operating expenses has changed by -$646.00 K (-2.50%)
What is Enlivex Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of ENLV is $2.99 M
What is the all time high quarterly operating expenses for Enlivex Therapeutics?
Enlivex Therapeutics all-time high quarterly total operating expenses is $7.84 M
What is Enlivex Therapeutics quarterly operating expenses year-on-year change?
Over the past year, ENLV quarterly total operating expenses has changed by -$2.64 M (-46.94%)